Wire · regulatory
Providers warn of another decade of 340B payment problems
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
The American Hospital Association warns that proposed CMS reimbursement cuts to the 340B Drug Pricing Program could trigger another decade of payment issues, following similar disputed cuts invalidated by the Supreme Court. The CMS plans to finalize significant payment formula changes in late 2026 despite provider opposition concerning survey validity and potential financial harm to hospitals servicing vulnerable populations.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
You face accelerating payment cuts for 340B drugs likely to strain hospital budgets serving vulnerable patients. This regulatory risk demands immediate financial planning and advocacy with CMS before the November 1 final rule.
◆ Coverage
1 source · 31 Aug 2026
◆ Related on Wire
◆ Topics